Gensenta is established in 1923, became an Amgen Company in 2012 Offering new and comprehensive solutions to more patients on a wider geography with main drug groups of: Hospital, Injections, Oncology, Antibiotics, Corticosteroids. There are more than 850 employees in Head office, API and FDF factories in Turkey. Gensenta is one of the most important finished drug product and pharmaceutical raw material manufacturers of Turkey also, first and most experienced manufacturer of parental drugs and lyophilized injectables. Gensenta, which is Turkey’s largest exporter in the pharmaceutical industry for two consecutive years in 2014 and 2015, is also the first company in Turkey to export oncology drugs to the USA and it is the first fill and finish of mab biosimilar CMO in Turkey. Gensenta exports its products to 6 continents and more than 50 countries.